On the other hand, Kumar et al. demonstrated that elevated proinflammatory cytokine levels (IFN-γ, TNF-α, IL-17A, and IL-1β) are characteristic of TB and that anti-TB therapy can modify these indicators, which are characteristic of the disease severity and the bacterial load. The gene discussed is IL17A; the disease is tuberculosis.